SCHEMBL3270630

SCHEMBL3270630

C=CCC(CC=C)C(CC=C)(CC=C)OC(N)=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.32
GRIK1 P39086 2/20 0.31
GRIK2 Q13002 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5696398 0.71 GRIK1 (0.36) HTTGRIK1GRIK2
SCHEMBL10762335 0.69
SCHEMBL11032795 0.68 HTT (0.35) HTT
SCHEMBL11602378 0.68 HTT (0.35) HTT
SCHEMBL7023420 0.68 HTT (0.35) HTT
SCHEMBL29021085 0.68 TDP1 (0.34) HTT
SCHEMBL3676128 0.67
SCHEMBL5696479 0.65 TSHR (0.33) GRIK1GRIK2
SCHEMBL28694555 0.64 HTT (0.33) HTT
SCHEMBL8850951 0.63 HTT (0.32) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068391-A1 OPTICAL ARTICLE COMPRISING A SUBSTRATE FOR MYOPIA CONTROL WITH EMBEDDED NANOPARTICLES ESSILOR INTERNATIONAL (FR) 2025-04-03 WO disclosed
EP-4530054-A1 OPTICAL ARTICLE COMPRISING A SUBSTRATE FOR MYOPIA CONTROL WITH EMBEDDED NANOPARTICLES Essilor International (FR) 2025-04-02 EP disclosed
EP-3665514-B1 OPTICAL ARTICLE COMPRISING A SUBSTRATE WITH EMBEDDED PARTICLES FOR LIGHT TRANSMISSION ENHANCEMENT ESSILOR INT (FR) 2024-10-02 EP disclosed
EP-3665515-B1 OPTICAL ARTICLE COMPRISING A SUBSTRATE WITH EMBEDDED PARTICLES FOR ABRASION AND/OR SCRATCH RESISTANCE ENHANCEMENT ESSILOR INT (FR) 2024-01-17 EP disclosed
US-11852784-B2 Optical article comprising a substrate with embedded particles for light transmission enhancement ESSILOR INTERNATIONAL (FR) 2023-12-26 US disclosed
CN-110734601-B Liquid and meltable solid grade scorch-protected peroxides 阿科玛股份有限公司 2022-12-09 CN disclosed
CN-109073781-B Optical materials comprising red-shifted benzotriazole UV absorbers 依视路国际公司 2022-08-02 CN disclosed
CN-107922755-B Free radical coating compositions with improved surface cure properties 阿科玛法国公司 2021-04-06 CN disclosed
US-10838111-B2 Optical material comprising a red-shifted benzotriazole UV absorber ESSILOR INTERNATIONAL (FR) 2020-11-17 US disclosed
US-20190107647-A1 OPTICAL MATERIAL COMPRISING A RED-SHIFTED BENZOTRIAZOLE UV ABSORBER ESSILOR INTERNATIONAL (FR) 2019-04-11 US disclosed
EP-3019561-B1 FREE RADICAL COATING COMPOSITION WITH IMPROVED SURFACE CURE PROPERTIES ARKEMA FRANCE (FR) 2018-11-21 EP disclosed
EP-3236296-A1 OPTICAL MATERIAL COMPRISING A RED-SHIFTED BENZOTRIAZOLE UV ABSORBER ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) 2017-10-25 EP disclosed
EP-3019561-A2 FREE RADICAL COATING COMPOSITION WITH IMPROVED SURFACE CURE PROPERTIES Arkema France (FR) 2016-05-18 EP disclosed
WO-2015004258-A2 FREE RADICAL COATING COMPOSITION WITH IMPROVED SURFACE CURE PROPERTIES ARKEMA FRANCE (FR) 2015-01-15 WO disclosed
US-7691557-B2 Polymerizable composition exhibiting permanent color change as cure indicator DYMAX CORPORATION (US) 2010-04-06 US disclosed
US-20070004836-A1 Polymerizable composition exhibiting permanent color change as cure indicator DYMAX CORPORATION 2007-01-04 US disclosed
US-6518441-B2 Method for oxidizing an organic compound containing at least one C-C double bond BASF AKTIENGESELLSCHAFT (DE) 2003-02-11 US disclosed
EP-1274759-A2 ALLYL URETHANE RESIN COMPOSITIONS SARTOMER COMPANY, INC. (US) 2003-01-15 EP disclosed
US-20020120158-A1 METHOD FOR OXIDIZING AN ORGANIC COMPOUND CONTAINING AT LEAST ON C-C DOUBLE BOND BASF AKTIENGESELLSCHAFT (DE) 2002-08-29 US disclosed
WO-2001072862-A2 ALLYL URETHANE RESIN COMPOSITIONS SARTOMER COMPANY, INC. (US) 2001-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190107647-A1 OPTICAL MATERIAL COMPRISING A RED-SHIFTED BENZOTRIAZOLE UV ABSORBER CRY2, ALDH1A2, CRY1 HTT 310/4885GRIK1 472/4885GRIK2 589/4885
US-10838111-B2 Optical material comprising a red-shifted benzotriazole UV absorber CRY2, ALDH1A2, CRY1 HTT 310/4885GRIK1 472/4885GRIK2 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.